Cite

    Doebele, R. et al. (2015). Phase 2, randomized, open‐label study of ramucirumab in combination with first‐line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non–small cell lung cancer. Cancer. 121 (6), pp. 883-892. [Online].